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ABSTRACT 
There is limited data on disclosure of Paediatric HIV to significant others in the social network of children which may impact on 
their care. This study determined the prevalence of disclosure of Paediatric HIV to infected children and others as well as their 
impact on the children. It took place at the Paediatric Infectious Disease Clinic of the University College Hospital, Ibadan. 
Caregivers of HIV positive school aged children were interviewed using a semi-structured questionnaire and the Parent version 
of the Strength and Difficulties Questionnaire. Data was analysed using IBM SPSS Statistics version 20.0. A total of 200 children 
were studied with a male: female ratio of 1.3:1 and ages ranging from 6-17 years.  Disclosure of HIV status had been done to 54 
(27%) of the 200 children. Disclosure was not associated with a significant difference in psychological functioning or adherence 
to ART. Disclosure had been made to extended family members in 128 (64%) of the 200 patients, to the children’s siblings in 33 
(21.4 %) of the 154 who had siblings, to the family spiritual leaders in 28 (14%) of the 200 families and to the children’s teachers 
in 3 (1.5%) of 197 cases in school. In response to disclosure, all the siblings, teachers and spiritual leaders encouraged the families 
and expressed willingness to support but this was so for only 108 (84.4%) of the 128 extended family members. Major forms of 
support given were financial, medication reminder, emotional support and prayers. Negative outcomes included stigmatization 
and HIV related parental separation. There is need for health workers to promote disclosure to significant others and provide 
support for families who get abandoned by relations following disclosure. 
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INTRODUCTION 
 
In 2017, about 180,000 children were newly infected with the 
Human immunodeficiency virus (HIV), bringing the total 
number of children under age 15 years living with HIV to 1.8 
million with nearly 90 per cent of these children living in sub-
Saharan Africa (UNICEF, 2018). In order to facilitate 
improved outcomes in these children, it is important for them 
to be aware of their diagnosis as disclosure of diagnosis may 
improve adherence to treatment, retention in care and 
psychological adjustment ( Battles 2002; Bikaako-Kajura et 
al., 2006; Haberer et al., 2011, Arrivé et al., 2012). 
 In spite of the benefits of disclosure, a recent review on 
disclosure of HIV status to children found that lower 
proportions of children in low and middle income countries 
(LMIC) knew their status compared to those in high-income 
countries: median prevalence of disclosure in lower and 
middle income countries was 20% in contrast to 43% in high 
income countries (Pinzon-Iregui, et al., 2013 ).  A major reason 
for delayed disclosure by parents is perceived emotional 
immaturity and fear of negative psychological impact on the 
child (Tadesse et al., 2015, Gyamfi et al., 2017). In spite of this 
fear, there is little data on the psychological impact of 
disclosure on infected children in Africa. 
 A systematic review on the impact of disclosure on 
adherence showed conflicting results with some showing no 
association, some others showing a negative impact of 
disclosure on adherence, and yet others showing positive 
benefits of disclosure for adherence habits (Nichols et al., 
2017). Disclosure of paediatric HIV status to others, may 
impact Paediatric ART adherence, children's well-being, and 
their social relationships. Beneficial impacts include improved 
ART adherence and better engagement of a helping social 
network (Vreeman et al., 2010). Potential adverse 
consequences include negative social effects such as 
discrimination against their families (Vreeman et al., 2010). 
However, the impacts of disclosure of children’s HIV status to 
others in developing countries have not been well studied.  The 
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objectives of this study were therefore to determine the 
prevalence of disclosure of Paediatric HIV to infected children 
and its impact on ART adherence and psychological 
functioning in the children. Other objectives were to determine 
the prevalence and pattern of disclosure to significant others as 
well as its impact on the child’s wellbeing. 
 
MATERIALS AND METHODS 
 
Study design and location: The design of the study was 
cross-sectional and it was carried out at the Paediatric 
Infectious Diseases clinic of the University College Hospital, 
Ibadan, a federal tertiary hospital in Oyo State, south west 
Nigeria. The clinic provides HIV care to children in Ibadan 
and serves as referral center for patients from neighboring 
cities.   
 
Study population: The target population was the primary 
caregivers of school age children living with HIV infection. 
These are the persons that are primarily responsible for the 
care of the children. Inclusion criteria were children aged 6 to 
17 years, who had been enrolled in the HIV care programme 
of the hospital for at least 6 months.  
 
Data collection: Caregivers of HIV positive children aged six 
years or more were invited to participate in the study, which 
took place between June and November 2016.  Data collection 
was through the use of 2 questionnaires that were administered 
to the parents or caregivers by the investigator and three other 
workers who were trained on its administration. The first 
questionnaire was a semi-structured questionnaire, 
administered to consecutive consenting caregivers in the 
absence of the children to ensure confidentiality and 
avoidance of unplanned disclosure. It was designed to capture 
socio-demographic data and explore the prevalence and 
pattern of disclosure to the children and significant others. 
Data obtained included socio-demographic variables, mode of 
acquisition of HIV infection by the child, whether or not 
disclosure had taken place, age at disclosure and impact on 
adherence to antiretroviral therapy (ART). Other data 
obtained included disclosure to significant others such as 
extended family members, siblings of patients, school teachers 
and family spiritual leaders as well as the responses and social 
impacts of these disclosures.  
 Disclosure to children in this study referred to telling the 
child specifically that he/she had AIDS or a viral infection 
called HIV. Socio-economic class stratification was based on 
the method by Oyedeji (Oyedeji, 1985).  Adherence was 
assessed by asking the caregivers about the number of missed 
doses of antiretroviral drugs in the preceding period of one 
month. The adherence rate was then computed. The perceived 
immediate psychological response of the children to 
disclosure was also documented.  This questionnaire was 
shared with a mental health expert for input and then translated 
from English to Yoruba, which is the predominant local 
language and subsequently translated back to English by 
another person to ensure it retained the original meaning. 
Questions that lost their original meaning during the 
translation process were re-translated to ensure they retained 
their original meaning. The questionnaire was then pre-tested 
on 10 respondents and adjusted as needed before actual 
commencement of enrolment.  
 The second questionnaire was the Strength and 
Difficulties Questionnaire (SDQ)-Parent report measures for 
children and adolescents aged 04-10 and 11-17 years 
(Goodman, 1997).  The English version of the SDQ was used 
to assess the psychosocial impact of disclosure on the child. 
The SDQ was designed, as both a clinical and an 
epidemiological research tool, to investigate children and 
adolescent’s attention or concentration, peer relations, 
prosocial behaviours, emotional symptoms and conduct or 
behavioural disorders (Goodman, 1997, Dickey, 2004, Akpa 
et al., 2015). It has been used to assess children’s psychosocial 
outcomes in several countries including Nigeria (Doku, 2009; 
Giannakopoulos et al., 2009, Akpa et al., 2015).  
 The SDQ consists of 25 items to assess a range of 
‘strengths’ and ‘difficulties’ as behavioural markers of 
potential mental health problems in children and adolescents. 
The items contribute to five subscales/domains of five items 
each with a minimum domain score of 0 (lowest score) to 10 
(highest score): conduct problems, hyperactivity/inattention, 
emotional symptoms, peer problems, and prosocial behaviour 
(Goodman, 1997).  The Total Difficulties score is generated 
by summing the scores from all the scales except the Prosocial 
scale. A higher total difficulty score indicates a greater 
likelihood of significant problems. The scores from each 
subscale as well as the total difficulties score were classified 
into normal (Emotional: 0-3, Conduct: 0-2, Hyperactivity: 0-
5. Peer problems: 0-2, Prosocial: 6-10 and Total difficulty: 0-
13), borderline (Emotional: 4, Conduct: 3, Hyperactivity: 6. 
Peer problems: 3, Prosocial: 5 and Total difficulty: 14-16) and 
abnormal (Emotional: 5-10, Conduct: 4-10, Hyperactivity: 7-
10. Peer problems: 4-10, Prosocial: 0-4 and Total difficulty: 
17-40). An abnormal score on the total difficulties scale can 
be used to identify likely cases with psychosocial affectation.  
 Consecutive mothers or caregivers of HIV infected 
children who met the inclusion criteria were invited to 
participate and those who gave informed consent were 
interviewed.  
 
Ethical consideration: Ethical approval for the study was 
obtained from the Ethics committee of the University of 
Ibadan and University College Hospital, Ibadan (Approval 
number: UI/EC/15/0281). 
 
Data Analysis: The information obtained from the 
questionnaire was entered into a spreadsheet and analysis was 
done using IBM SPSS Statistics version 20.0 software. 
Summary statistics was computed for continuous variables 
and means compared using t-test or Analysis of variance 
(ANOVA) as applicable. Categorical variables were described 
in frequencies and proportions. Associations were tested using 




A total of 200 children were studied with a male: female ratio 
of 1.3:1. Their ages ranged from 6-17 years with a mean 
(Standard deviation=SD) of 10.2(2.7) years.  HIV infection 
was acquired through mother-to-child transmission in 
198(99.0%) and through transfusion with infected blood in 
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2(1.0%) of the children. Out of the 200 children studied, 198 
(99.0%) had HIV positive mothers, 2(1%) had HIV negative 
mothers, 106 (53.0%) had HIV positive fathers, 89 (44.5%) 
had HIV negative fathers and 5 (2.5%) had fathers with 
unknown HIV status. 
 Disclosure of HIV status had been done to 54 (27%) of 
the 200 children and the age at disclosure varied from 5-16 
years with a mean (SD) of 11.3(2.5) years. 
 
Impact of Disclosure to Child  
Out of the 200 patients studied, 199 were on antiretroviral 
therapy (ART) and assessed for impact of disclosure on 
adherence. Adherence to antiretroviral therapy was 95% in 49 
(92.5%) of the 53 patients to whom HIV disclosure had been 
done, compared with 138 (94.5%) of the 146 in whom 
disclosure had not been done (Fisher’s exact test p =0.736). 
 Analysis of parental perception of the impact of 
disclosure revealed that no impact was observed in 46.3%, 
improved drug adherence in 35.2% and depression shortly 
after disclosure in 18.5% (table 1). The children with 
improved adherence became more willing to take their 
medications. The children who were depressed had a higher 
mean (SD) age of 12.8(1.9) years while those with no obvious 
impact was observed had a lower mean (SD) age of 10.1 (2.3) 
years (ANOVA, F= 6.413, p =0.003) as shown in Table 1. 
Table 1:  
Parental perception of impact of disclosure  
 Frequency  Percent  Mean Age (SD) in 
years 
No impact 25 46.3 10.1 (2.3) 
Improved 
adherence  
19 35.2 11.9(2.4) 
Depression  10 18.5 12.8(1.9) 
Total  54 100 11.3 (2.5) 
SD= Standard deviation  
 
Psychological Functioning 
Analysis of psychological functioning of the children using 
the strength and difficulties questionnaire revealed that 
abnormal functioning was present in 2% of the cohort on the 
hyperactivity scale, 3% on the emotional symptom scale, 1.5% 
on the Prosocial scale, 2.5% on the conduct problem scale, 
14% on the Peer problem scale and 2.5% on the total difficulty 
scale (table 2). There was no statistically significant difference 
in the percentage of children with abnormal function between 
those to whom HIV status disclosure had been made and those 
to whom it had not been made (Table 2).  
 
Table 2:  
Relationship between HIV status disclosure and Psychological functioning   
Disclosure Abnormal Borderline Normal Total p-value 
      
Hyperactivity Scale(HAS) 
Yes 0(0) 1(1.9) 53(98.1) 54(100)  
No 4(2.7) 2(1.4) 140(95.9) 146(100) 0.65 
Total 
 
4(2) 3(1.5) 193(96.5) 200(100)  
Emotion Symptom Scale(ESS) 
Yes   4(7.4) 1(1.9) 49(90.7) 54(100)  
No   2(1.4) 6(4.1) 138(94.5) 146(100) 0.07 
Total   6(3.0) 7(3.5) 187(93.5) 200(100)  
      
Prosocial scale(PSS)      
Yes   1(1.9) 2(3.7) 51(94.4) 54(100)  
No   2(1.4) 0(0) 144(98.6) 146(100) 0.90 
Total   3(1.5) 2(1.0) 195(97.5) 200(100)  
      
Conduct Problem scale(CPS) 
Yes   1(1.9) 2(3.7) 51(94.4) 54(100)  
No   4(2.7) 15(10.3) 127(87.0) 146(100) 0.341 
Total   5(2.5)  17(8.5) 178(89.0) 200(100)  
      
Peer Problem scale(PPS) 
Yes   7(13.0) 19(35.2) 28(51.9) 54(100)  
No   21(14.4) 57(39.0)  68(46.6) 146(100) 0.82 
Total   28(14.0)  76(38)  96(48.0) 200(100)  
      
Total Difficulties scale(TDS) 
Yes   1(1.9) 2(3.7) 51(94.4) 54(100)  
No   4(2.7) 8(5.5) 134(91.8) 146(100) 0.90 
Total   5(2.5) 10(5.0) 185(92.5) 200(100)  
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Table 3:  










Financial only 44 40.7 
Financial and food  16 14.8 
Financial and prayers 19 17.6 
Bringing child to clinic 16 14.8 




Reminder to take drugs 17 51.5 
Taking the child to the 
clinic 
6 18.2 
Financial  7 21.2 










Prayers and donation 
of cash and kind 
(foodstuff) 
9 32.1 
Donation of cash and 
kind alone in 
2 7.1 
Caregiving for the 
child whenever the 






Assistance with class 
work  
1 33.3 
Emotional  1 33.3 
Financial  1 33.3 
 
Disclosure of child’s HIV status to significant others  
Disclosure of HIV status had been done to extended family 
members in 128 (64%) of the 200 patients, to the children’s 
siblings in 33 (21.4 %) of the 154 who had siblings, to the 
family spiritual leaders in 28 (14%) of the 200 families and to 
the children’s teachers in 3 (1.5%) of 197 cases in school.  
Out of the 130 Christian families in the study, 23 (17.7%) had 
disclosed to their spiritual leaders compared with 5 (7.1%) out 
the 70 Muslim families who disclosed to their spiritual leaders 
(Pearson Chi square, P value =0.040).  
 Among the 128 children in whom disclosure had been 
done to family members, it was done to the patients’ maternal 
relatives in 59 (46.1%) cases, to the paternal relatives in 46 
(35.9%) cases and to both maternal and paternal relatives in 
23(18.0%) cases.  In terms of time interval between diagnosis 
of HIV infection in the children and disclosure to family 
members, it was done immediately in 103 (80.5%), weeks 
after diagnosis in 4 (3.1%), months after diagnosis in 3(2.3%) 
and years after in 18 (14.1%) cases.  
 The reason for disclosure to family members was to 
explain chronic illness, death and use of drugs in 105 (82.0%) 
cases, the need because of relationship ties in 9 (7.0%) and in 
order to receive support in 8 (6.3%) cases. No particular 
reason was given for disclosure in the remaining 6 cases. 
 
Response and Impact of Disclosure to family members and 
significant others 
 In response to disclosure, all the siblings, teachers and 
spiritual leaders encouraged the families and expressed 
willingness to support but this was so for only 108 (84.4%) of 
the 128 extended family members. Table 3 shows the forms of 
support received and indicates that the major form of support 
given by extended family members was financial, that by 
siblings was medication reminder, by spiritual leaders was 
emotional support and prayers.    
 In 24 (18.8%) of the 128 families to whom disclosure had 
been made, they avoided play and interaction between their 
children and the HIV infected child. This includes 15 families 
that were otherwise supportive to the affected child and 
family.  With regards to the marital status of parents of the 200 
children studied, 172 (86%) were married, 1 (0.5%) was not 
married and 27 (13.5%) were separated, the father having 
abandoned the child to the care of the mother. Separation was 
related to disclosure of the child’s HIV diagnosis in 23 
(85.2%) of the 27 cases of separation. The 23 cases of HIV 
related separation represent 11.5% of the study participants. 
Separation was at the instance of the child’s father in 19 (82.6) 
%, at the instance of the father’s relatives in 2 (8.7%) and at 
the instance of the mother in 2 (8.7%) of the 23 children.   
 There was no statistically significant association between 
parental separation as a result of the child’s HIV status and 
religion, father’s HIV status, socio-economic class and 
disclosure to spiritual leaders. 
 
 
Table 4:  
Relationship between socio-demographic factors and 
parental separation   










Upper 6 12.2 49 0.802 
Lower  17 11.1 151  
Religion Christianity 15 11.5 130 1.000 
Islam 8 11.4 70  
Father’s 
HIV status 
Positive  9 8.5 106 0.186 




Yes 4 14.3 28 0.538 
No 19 11.0 172  




The 27% prevalence of disclosure in our study is similar to 
26% reported in Western Kenya but less than the 32.6% 
reported by Nzota et al in Tanzania (Nzota et al., 2015; 
Vreeman et al., 2014). It is however an improvement on 
13.5% reported previously in the same setting and infers an 
increased awareness by caregivers on the importance of 
adherence over the years (Brown et al., 2011).  However, there 
is still need for improvement as disclosure rates as high as 
65% have been recorded in other African settings without any 
significant emotional disturbance (Binagwaho et al., 2012).  
 Disclosure has been shown to improve adherence to 
antiretroviral drugs in children (Ugwu & Eneh, 2013). In our 
study, caregivers voluntarily expressed improved adherence in 
about a third of the children following disclosure in keeping 
with findings in Uganda (Bikaako-Kajura et al., 2006).  
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However, disclosure was not associated with a statistically 
significant difference in adherence in the entire study 
population.  It is possible that children to whom disclosure had 
not been done achieved adherence through force, coercion or 
other efforts by the caregivers as alluded to by Bikaako-kajura 
et al (2006). However self-motivated adherence which is seen 
in disclosed children is better in the long run as the children 
grow up to be independent of their caregivers.  The routine 
adherence counselling that takes place at the monthly drug 
pick up appointments for each child in our clinic might have 
also contributed to the absence of a negative impact of non-
disclosure on adherence as well as the high 95% disclosure 
score which was recorded in over 90% of the patients.  
 About one-fifth of the children were depressed 
immediately after disclosure according to parental perception. 
This was associated with older age of the children and 
reasonably due to better understanding of the lifelong course 
of HIV infection by older children. This calls for some 
professional psychological support during the process of 
disclosure especially for this subset of children.  However, 
using the Strengths and Difficulties Questionnaire, the study 
revealed no significant difference in psychological 
functioning of children irrespective of their disclosure status. 
This is in keeping with findings by other workers in Africa 
(Adefalu et al., 2016; Kalembo et al., 2019).  This is a 
reassuring piece of information for parents since a barrier to 
disclosure expressed by caregivers in previous studies is fear 
of psychological harm to the children (Gyamfi et al., 2017).   
 This study has not only shown the pattern of disclosure of 
family members but also to significant others like religious 
leaders, school teachers and siblings of the infected children. 
The major reason for disclosure to family members was to 
explain chronic illness, death and use of drugs. Disclosure to 
the child’s school teacher and family spiritual leaders were 
low but worse with the school teachers. Christians were also 
more likely to disclose to their spiritual leaders than Muslims.  
Nevertheless, the yield was a supportive response from the 
teachers and religious spiritual leaders irrespective of religious 
inclination. The 64% disclosure rate to extended family 
members implies that disclosure had not been done in over a 
third of families. This may constitute a psychological burden 
of secrecy for affected families, requiring counselling and 
psychological support.   
 Disclosure of diagnosis by adult HIV patients have been 
known to engender support such as improved care and 
material support (Atuyambe., 2014). Our study similarly 
revealed financial and material support granted to children by 
various groups of individuals to whom disclosure had been 
made. In the cultural context of some African settings, caring 
for children, including sustaining ART adherence, usually 
involves the support of a network of family and community 
members (Vreeman et al., 2009). Caregivers in the present 
study described a wide range of support received from the 
different persons disclosed to support in cash and kind and 
assistance in taking the child to the clinic, caring for the child 
at home whenever the parent was away from home and 
emotional support. All these forms of support are better 
appreciated when one considers the fact that the need for 
regular clinic visits for the child and provision of home care 
for the children when ill creates a burden of absenteeism from 
work on the parents; these are taken care of by supporters to 
whom disclosure have been made.  In our study, siblings 
assisted with taking HIV infected children to the clinic and 
also reminded them to take their medications, which 
facilitated adherence. Similarly, caregivers in Kenya have 
reported that family members to whom disclosure has been 
made assist with administration of medications to the children 
(Vreeman et al., 2010).  Our study has shown several forms of 
social support derivable through disclosure to others and the 
need to explore and harness them in the care of children 
infected with HIV.  
On the negative side, in almost a fifth of the cases of disclosure 
to extended family members, the latter prevented their 
children from playing with the HIV infected children. This 
form of stigmatization has been described by other workers 
and calls for better public enlightenment and support for 
affected families during the disclosure process (Vreeman et 
al., 2010).  Disclosure to family members also resulted in 
parental separation and paternal abandonment of the HIV 
infected child with the mother in 11.5% of the study 
participants. Although there was no association between the 
father’s HIV status and the parental separation, it was mostly 
at the instance of the father. Social support and family 
counselling is therefore required in the process of disclosure 
especially for women who seem to be at the receiving end.  
 This study has thrown some light on disclosure of 
Paediatric HIV status to others, a subject that had hitherto been 
largely neglected. The supportive response by most of the 
people to whom disclosure was made and the forms of support 
received is an encouragement to promote this form of 
disclosure. The instances of family conflict, child 
abandonment and stigmatization that result call for support 
from the health institutions and state social welfare 
departments. More studies are required to better define the 
pattern and outcomes of disclosure of paediatric HIV status to 
others.   
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